ENTRY       D11406                      Drug
NAME        Risdiplam (JAN/USAN/INN);
            Evrysdi (TN)
PRODUCT     EVRYSDI (Genentech)
FORMULA     C22H23N7O
EXACT_MASS  401.1964
MOL_WEIGHT  401.4643
CLASS       Metabolizing enzyme substrate
             DG01891  CYP1A1 substrate
             DG02954  CYP2J2 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG03121  CYP3A7 substrate
             DG03191  FMO1 substrate
             DG02950  FMO3 substrate
REMARK      Therapeutic category: 1190
            ATC code: M09AX10
            Product: D11406<JP/US>
EFFICACY    Protein modulator
  DISEASE   Spinal muscular atrophy [DS:H00455]
COMMENT     Treatment of Spinal muscular atrophy (SMA)
TARGET      SMN2 [HSA:6607] [KO:K13129]
  PATHWAY   hsa03013(6607)  Nucleocytoplasmic transport
METABOLISM  Enzyme: FMO1 [HSA:2326], FMO3 [HSA:2328], CYP1A1 [HSA:1543], CYP2J2 [HSA:1573], CYP3A4 [HSA:1576], CYP3A7 [HSA:1551]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
               M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
                M09AX Other drugs for disorders of the musculo-skeletal system
                 M09AX10 Risdiplam
                  D11406  Risdiplam (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Risdiplam
               D11406  Risdiplam (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               119  Miscellaneous
                1190  Miscellaneous
                 D11406  Risdiplam (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01891  CYP1A1 substrate
               D11406  Risdiplam
              DG02954  CYP2J2 substrate
               D11406  Risdiplam
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D11406  Risdiplam
              DG03121  CYP3A7 substrate
               D11406  Risdiplam
              DG03191  FMO1 substrate
               D11406  Risdiplam
              DG02950  FMO3 substrate
               D11406  Risdiplam
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Signaling molecules
               Spliceosome
                SMN2
                 D11406  Risdiplam (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11406
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11406
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11406
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11406
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11406
DBLINKS     CAS: 1825352-65-5
            PubChem: 384585384
ATOM        30
            1   N4y N    11.2000  -15.1900
            2   C8y C    11.2000  -16.5900
            3   C8y C    12.3900  -17.2900
            4   C8x C    13.6500  -16.5900
            5   C8y C    13.6500  -15.1900
            6   N5x N    12.3900  -14.4900
            7   C8x C     9.8700  -14.7700
            8   C8y C     9.0300  -15.8900
            9   N5x N     9.8700  -17.0100
            10  C1a C    12.3900  -18.6900
            11  C1a C     7.6300  -15.8900
            12  C8y C    14.8400  -14.4900
            13  N5x N    16.0300  -15.1900
            14  C8y C    17.2900  -14.4900
            15  N4y N    17.2900  -13.0900
            16  C8y C    16.1000  -12.3900
            17  C8x C    14.8400  -13.0900
            18  C8x C    18.4800  -15.1900
            19  C8x C    19.6700  -14.4900
            20  C8y C    19.6700  -13.0900
            21  C8x C    18.4800  -12.3900
            22  N1y N    20.8600  -12.3900
            23  C1x C    22.0500  -13.0900
            24  C1x C    23.3100  -12.3900
            25  N1x N    23.3100  -10.9900
            26  C1z C    22.1200  -10.2900
            27  C1x C    20.8600  -10.9900
            28  C1x C    22.8200   -9.1000
            29  C1x C    21.4200   -9.1000
            30  O5x O    16.1172  -10.9901
BOND        35
            1     1   2 1
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 2
            9     8   9 1
            10    2   9 2
            11    3  10 1
            12    8  11 1
            13    5  12 1
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17   15  16 1
            18   16  17 1
            19   12  17 2
            20   14  18 1
            21   18  19 2
            22   19  20 1
            23   20  21 2
            24   15  21 1
            25   20  22 1
            26   22  23 1
            27   23  24 1
            28   24  25 1
            29   25  26 1
            30   26  27 1
            31   22  27 1
            32   28  29 1
            33   29  26 1
            34   26  28 1
            35   16  30 2
///
